Context Therapeutics (CNTX) Technical Analysis

As of 2026-07-22, CNTX last traded at 0.6134 USD (-2.63% on the day) and is in a downtrend on the daily timeframe — price below falling 50-DMA, 50-DMA below 200-DMA. Nearest levels: 0.5601 USD support below, 0.7021 USD resistance above. 14-day RSI is 50.6 (neutral).

Last updated 2026-07-22 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ

Is CNTX in an uptrend or downtrend?

Context Therapeutics is in a downtrend — price below falling 50-DMA, 50-DMA below 200-DMA.

Last close0.6134 USD (-2.63%)
20-day average0.61203 USD
50-day average1.383 USD
200-day average1.752 USD

Key support and resistance levels for CNTX

Derived from swing pivots over the last 200 sessions:

LevelTypeStrengthTouches
0.7021 USDResistanceMinor1
1.13 USDResistanceMinor1
1.18 USDResistanceMinor1
LevelTypeStrengthTouches
0.5601 USDSupportMinor1
0.5451 USDSupportMinor1

CNTX 52-week range, momentum and volatility

52-week high3.62 USD (83.1% below)
52-week low0.5451 USD (12.5% above)
14-day RSI50.6 (Neutral)
14-day ATR0.05685 USD (9.27% of price, High volatility)

Related research pages

Frequently asked questions

Is Context Therapeutics (CNTX) in an uptrend or downtrend?

As of 2026-07-22, CNTX is in a downtrend on the daily timeframe — price below falling 50-DMA, 50-DMA below 200-DMA. Last close 0.6134 USD vs 50-day average 1.38347 USD and 200-day average 1.75172 USD.

What are the key support and resistance levels for CNTX?

Nearest support is around 0.5601 USD (minor, 1 touch). Nearest resistance is around 0.7021 USD (minor). Levels are derived from swing pivots over the last ~200 sessions.

What is CNTX's 52-week high and low?

Over the last 52 weeks, CNTX traded between 0.5451 USD and 3.62 USD. It is currently 83.1% below its 52-week high.

Is CNTX overbought or oversold?

The 14-day RSI is 50.6 — in a neutral 30–70 range. Momentum reads as neutral.

How volatile is CNTX?

Its 14-day Average True Range is 0.05685 (9.27% of price) — high volatility relative to price.